[
AbbVie reports $744 million IPR&D expense for Q1, updates 2026 earnings guidance
[og_img]
https://www.investing.com/news/sec-filings/abbvie-reports-744-million-iprd-expense-for-q1-updates-2026-earnings-guidance-93CH-4597303
Investing.com
AbbVie reports $744 million IPR&D expense for Q1, updates 2026 earnings guidance
Related articles
